Ovarian Cancer Clinical Trials in Atlanta

Showing 121-122 of 122 trials

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

NCT00465725

Picoplatin is a new platinum-based chemotherapy drug that has been studied in a variety of cancers. Phase 1 and 2 studies have demonstrated that picoplatin may be effective in patients whose cancer returns or does not improve after treatment with chemotherapy. In these studies, picoplatin was administered intravenously. A capsule containing picoplatin has been formulated. This study will investigate the activity of the oral capsule in humans. Participants with advanced solid tumors will be enrolled.

Bladder CancerBreast CancerColorectal Cancer+6 more

Poniard Pharmaceuticals18 participantsStarted Apr 2007

Atlanta, Georgia, United States • Las Vegas, Nevada, United States • Tacoma, Washington, United States

TERMINATEDPHASE3104 miles

Clinical Trial for Ovarian Cancer (OvaRex®)

NCT00050375

This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients. This study will also compare assessments of survival, quality of life, immune response and safety between active and placebo groups.

Ovarian Cancer

Unither Pharmaceuticals354 participantsStarted Dec 2002

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +59 more locations

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Clinical Trial for Ovarian Cancer (OvaRex®)

Ovarian Cancer Trials in Other Cities

Other Conditions in Atlanta